
An inhibitory function for JNK in the regulation of IGF-I ... - Nature
2003年1月29日 · Taxol and other chemotherapy drugs induce c-Jun N-terminal kinase (JNK), a kinase that conveys cellular stress and death signals. Notably, in this paper we show that IGF-I alone induces a...
The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF …
2016年2月22日 · Inhibition of ERK1/2 or JNK signaling abolishes the proliferative and anti-apoptotic effects of insulin/IGF-1 in vitro. MC38 cells were cultured with insulin and IGF-1 alone or both together for 72 hours.
Insulin-like growth factor-1 activates Akt and Jun N-terminal …
We found that IGF-1 transiently induces Akt, jun N-terminal kinases (JNK), and c-Jun phosphorylation in activated T cells, with JNK and c-Jun phosphorylation occurring faster than Akt phosphorylation. To mimic IGF-1R expression levels in CD28-stimulated Jurkat cells these cells were stably transfected to over-express the IGF-1R.
Insulin-like growth factor 1 enhances the proliferation and
Together, the results showed that IGF-1 can promote the osteogenic differentiation and osteogenesis of STRO-1 (+) PDLSCs via ERK and JNK MAPK pathway, suggesting that IGF-1 is a potent agent for stem cell-based periodontal tissue regeneration.
SHC-1/p52Shc targets the insulin/IGF-1 and JNK signaling …
2008年10月1日 · SHC-1 acts upstream of the insulin/IGF receptor DAF-2 and the PI3 kinase AGE-1 and directly interacts with DAF-2. Moreover, SHC-1 activates JNK signaling by binding to MEK-1 kinase. Both aspects converge on controlling the nuclear translocation and activation of the FOXO transcription factor DAF-16.
The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF …
2016年2月22日 · Treatment with ERK1/2 or JNK inhibitor in the presence of insulin and IGF-1 significantly decreased B-cell lymphoma 2 (Bcl-2) and increased Bcl-2-associated X protein (Bax) expression and finally increased apoptosis and inhibited the proliferation.
The Essential Role of the Death Domain Kinase Receptor …
Here, we show that the receptor-interacting protein (RIP), a key mediator of tumor necrosis factor-induced NF-κB and JNK activation, plays a key role in IGF-I receptor signaling. IGF-I induced a robust JNK activation in wild type but not RIP null (RIP–/–) mouse embryonic fibroblast cells.
SHC-1/p52Shc targets the insulin/IGF-1 and JNK signaling
2008年10月1日 · SHC-1 acts upstream of the insulin/IGF receptor DAF-2 and the PI3 kinase AGE-1 and directly interacts with DAF-2. Moreover, SHC-1 activates JNK signaling by binding to MEK-1 kinase. Both aspects converge on controlling the nuclear translocation and activation of the FOXO transcription factor DAF-16.
IGF-I attenuates FFA-induced activation of JNK1 phosphorylation …
Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c-Jun N-terminal kinase (JNK) activation and expression of TNFα. Given that IGF-I-mediated proliferation is impaired in ...
An inhibitory function for JNK in the regulation of IGF-I signaling …
2003年1月30日 · Taxol and other chemotherapy drugs induce c-Jun N-terminal kinase (JNK), a kinase that conveys cellular stress and death signals. Notably, in this paper we show that IGF-I alone induces a potent JNK response and this activity is reversed by inhibition of phosphatidylinositol 3-kinase (PI 3-kinase) with LY294002 in MCF-7 but not T47D cells.